Journal article 1835 views 241 downloads
A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism
British Journal of Haematology, Volume: 168, Issue: 4, Pages: 571 - 575
Swansea University Authors:
Matthew Lawrence , Ahmed Sabra, Karl Hawkins
, Daniel Curtis
, Rowan Brown
, Lindsay D´Silva, Rhodri Williams
, Adrian Evans
-
PDF | Accepted Manuscript
Download (530.67KB)
DOI (Published version): 10.1111/bjh.13173
Abstract
This study compared patients with venous thromboembolism (VTE) to non‐VTE patients using a biomarker of clot microstructure (df) and clot formation time (TGP). df was the only marker that identified a significant difference (P < 0·001) between the VTE (n = 60) and non‐VTE cohorts (n = 69). The ‘a...
Published in: | British Journal of Haematology |
---|---|
ISSN: | 0007-1048 1365-2141 |
Published: |
Wiley
2015
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa27555 |
first_indexed |
2016-04-30T01:13:03Z |
---|---|
last_indexed |
2025-03-29T03:53:26Z |
id |
cronfa27555 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2025-03-28T15:11:47.3834750</datestamp><bib-version>v2</bib-version><id>27555</id><entry>2016-04-29</entry><title>A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism</title><swanseaauthors><author><sid>262d0cae7663ded863d6e2de15757f3c</sid><ORCID>0000-0001-7344-2836</ORCID><firstname>Matthew</firstname><surname>Lawrence</surname><name>Matthew Lawrence</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>97b3ad56338338453cbee42046817655</sid><ORCID/><firstname>Ahmed</firstname><surname>Sabra</surname><name>Ahmed Sabra</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>77c39404a9a98c6e2283d84815cba053</sid><ORCID>0000-0003-0174-4151</ORCID><firstname>Karl</firstname><surname>Hawkins</surname><name>Karl Hawkins</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>e76ff28a23af2fe37099c4e9a24c1e58</sid><ORCID>0000-0002-6955-0524</ORCID><firstname>Daniel</firstname><surname>Curtis</surname><name>Daniel Curtis</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>d7db8d42c476dfa69c15ce06d29bd863</sid><ORCID>0000-0003-3628-2524</ORCID><firstname>Rowan</firstname><surname>Brown</surname><name>Rowan Brown</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>01ccf114efd431d0cab9b3ef591d7f02</sid><ORCID/><firstname>Lindsay</firstname><surname>D´Silva</surname><name>Lindsay D´Silva</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>642bf793695f412ed932f1ea4d9bc3f1</sid><ORCID>0000-0002-6912-5288</ORCID><firstname>Rhodri</firstname><surname>Williams</surname><name>Rhodri Williams</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>21761f6eb805546a561c9f036e85405b</sid><firstname>Adrian</firstname><surname>Evans</surname><name>Adrian Evans</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-04-29</date><deptcode>MEDS</deptcode><abstract>This study compared patients with venous thromboembolism (VTE) to non‐VTE patients using a biomarker of clot microstructure (df) and clot formation time (TGP). df was the only marker that identified a significant difference (P < 0·001) between the VTE (n = 60) and non‐VTE cohorts (n = 69). The ‘abnormal’ clot microstructures in the VTE patients suggests either inadequate response to anticoagulant therapy or the presence of a procoagulant state not detected by other markers of coagulation (i.e., International Normalized Ratio). Furthermore, elevated values of df in first time VTE patients who later develop a secondary event indicates that df may identify those at risk of recurrence.</abstract><type>Journal Article</type><journal>British Journal of Haematology</journal><volume>168</volume><journalNumber>4</journalNumber><paginationStart>571</paginationStart><paginationEnd>575</paginationEnd><publisher>Wiley</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0007-1048</issnPrint><issnElectronic>1365-2141</issnElectronic><keywords/><publishedDay>1</publishedDay><publishedMonth>2</publishedMonth><publishedYear>2015</publishedYear><publishedDate>2015-02-01</publishedDate><doi>10.1111/bjh.13173</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2025-03-28T15:11:47.3834750</lastEdited><Created>2016-04-29T11:29:28.3226576</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Matthew</firstname><surname>Lawrence</surname><orcid>0000-0001-7344-2836</orcid><order>1</order></author><author><firstname>Ahmed</firstname><surname>Sabra</surname><orcid/><order>2</order></author><author><firstname>Gavin</firstname><surname>Mills</surname><order>3</order></author><author><firstname>Suresh G.</firstname><surname>Pillai</surname><order>4</order></author><author><firstname>Wendy</firstname><surname>Abdullah</surname><order>5</order></author><author><firstname>Karl</firstname><surname>Hawkins</surname><orcid>0000-0003-0174-4151</orcid><order>6</order></author><author><firstname>Roger H. K.</firstname><surname>Morris</surname><order>7</order></author><author><firstname>Simon J.</firstname><surname>Davidson</surname><order>8</order></author><author><firstname>Lindsay A.</firstname><surname>D'Silva</surname><order>9</order></author><author><firstname>Daniel</firstname><surname>Curtis</surname><orcid>0000-0002-6955-0524</orcid><order>10</order></author><author><firstname>Rowan</firstname><surname>Brown</surname><orcid>0000-0003-3628-2524</orcid><order>11</order></author><author><firstname>John W.</firstname><surname>Weisel</surname><order>12</order></author><author><firstname>Phylip R.</firstname><surname>Williams</surname><order>13</order></author><author><firstname>Phillip A.</firstname><surname>Evans</surname><order>14</order></author><author><firstname>Lindsay</firstname><surname>D´Silva</surname><orcid/><order>15</order></author><author><firstname>Rhodri</firstname><surname>Williams</surname><orcid>0000-0002-6912-5288</orcid><order>16</order></author><author><firstname>Adrian</firstname><surname>Evans</surname><order>17</order></author></authors><documents><document><filename>27555__8327__61e0b5bf553741baa94b468f39d8127b.pdf</filename><originalFilename>27555.pdf</originalFilename><uploaded>2018-03-19T11:46:20.0030000</uploaded><type>Output</type><contentLength>543402</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2017-04-25T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
spelling |
2025-03-28T15:11:47.3834750 v2 27555 2016-04-29 A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism 262d0cae7663ded863d6e2de15757f3c 0000-0001-7344-2836 Matthew Lawrence Matthew Lawrence true false 97b3ad56338338453cbee42046817655 Ahmed Sabra Ahmed Sabra true false 77c39404a9a98c6e2283d84815cba053 0000-0003-0174-4151 Karl Hawkins Karl Hawkins true false e76ff28a23af2fe37099c4e9a24c1e58 0000-0002-6955-0524 Daniel Curtis Daniel Curtis true false d7db8d42c476dfa69c15ce06d29bd863 0000-0003-3628-2524 Rowan Brown Rowan Brown true false 01ccf114efd431d0cab9b3ef591d7f02 Lindsay D´Silva Lindsay D´Silva true false 642bf793695f412ed932f1ea4d9bc3f1 0000-0002-6912-5288 Rhodri Williams Rhodri Williams true false 21761f6eb805546a561c9f036e85405b Adrian Evans Adrian Evans true false 2016-04-29 MEDS This study compared patients with venous thromboembolism (VTE) to non‐VTE patients using a biomarker of clot microstructure (df) and clot formation time (TGP). df was the only marker that identified a significant difference (P < 0·001) between the VTE (n = 60) and non‐VTE cohorts (n = 69). The ‘abnormal’ clot microstructures in the VTE patients suggests either inadequate response to anticoagulant therapy or the presence of a procoagulant state not detected by other markers of coagulation (i.e., International Normalized Ratio). Furthermore, elevated values of df in first time VTE patients who later develop a secondary event indicates that df may identify those at risk of recurrence. Journal Article British Journal of Haematology 168 4 571 575 Wiley 0007-1048 1365-2141 1 2 2015 2015-02-01 10.1111/bjh.13173 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2025-03-28T15:11:47.3834750 2016-04-29T11:29:28.3226576 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Matthew Lawrence 0000-0001-7344-2836 1 Ahmed Sabra 2 Gavin Mills 3 Suresh G. Pillai 4 Wendy Abdullah 5 Karl Hawkins 0000-0003-0174-4151 6 Roger H. K. Morris 7 Simon J. Davidson 8 Lindsay A. D'Silva 9 Daniel Curtis 0000-0002-6955-0524 10 Rowan Brown 0000-0003-3628-2524 11 John W. Weisel 12 Phylip R. Williams 13 Phillip A. Evans 14 Lindsay D´Silva 15 Rhodri Williams 0000-0002-6912-5288 16 Adrian Evans 17 27555__8327__61e0b5bf553741baa94b468f39d8127b.pdf 27555.pdf 2018-03-19T11:46:20.0030000 Output 543402 application/pdf Accepted Manuscript true 2017-04-25T00:00:00.0000000 true eng |
title |
A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism |
spellingShingle |
A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism Matthew Lawrence Ahmed Sabra Karl Hawkins Daniel Curtis Rowan Brown Lindsay D´Silva Rhodri Williams Adrian Evans |
title_short |
A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism |
title_full |
A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism |
title_fullStr |
A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism |
title_full_unstemmed |
A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism |
title_sort |
A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism |
author_id_str_mv |
262d0cae7663ded863d6e2de15757f3c 97b3ad56338338453cbee42046817655 77c39404a9a98c6e2283d84815cba053 e76ff28a23af2fe37099c4e9a24c1e58 d7db8d42c476dfa69c15ce06d29bd863 01ccf114efd431d0cab9b3ef591d7f02 642bf793695f412ed932f1ea4d9bc3f1 21761f6eb805546a561c9f036e85405b |
author_id_fullname_str_mv |
262d0cae7663ded863d6e2de15757f3c_***_Matthew Lawrence 97b3ad56338338453cbee42046817655_***_Ahmed Sabra 77c39404a9a98c6e2283d84815cba053_***_Karl Hawkins e76ff28a23af2fe37099c4e9a24c1e58_***_Daniel Curtis d7db8d42c476dfa69c15ce06d29bd863_***_Rowan Brown 01ccf114efd431d0cab9b3ef591d7f02_***_Lindsay D´Silva 642bf793695f412ed932f1ea4d9bc3f1_***_Rhodri Williams 21761f6eb805546a561c9f036e85405b_***_Adrian Evans |
author |
Matthew Lawrence Ahmed Sabra Karl Hawkins Daniel Curtis Rowan Brown Lindsay D´Silva Rhodri Williams Adrian Evans |
author2 |
Matthew Lawrence Ahmed Sabra Gavin Mills Suresh G. Pillai Wendy Abdullah Karl Hawkins Roger H. K. Morris Simon J. Davidson Lindsay A. D'Silva Daniel Curtis Rowan Brown John W. Weisel Phylip R. Williams Phillip A. Evans Lindsay D´Silva Rhodri Williams Adrian Evans |
format |
Journal article |
container_title |
British Journal of Haematology |
container_volume |
168 |
container_issue |
4 |
container_start_page |
571 |
publishDate |
2015 |
institution |
Swansea University |
issn |
0007-1048 1365-2141 |
doi_str_mv |
10.1111/bjh.13173 |
publisher |
Wiley |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
description |
This study compared patients with venous thromboembolism (VTE) to non‐VTE patients using a biomarker of clot microstructure (df) and clot formation time (TGP). df was the only marker that identified a significant difference (P < 0·001) between the VTE (n = 60) and non‐VTE cohorts (n = 69). The ‘abnormal’ clot microstructures in the VTE patients suggests either inadequate response to anticoagulant therapy or the presence of a procoagulant state not detected by other markers of coagulation (i.e., International Normalized Ratio). Furthermore, elevated values of df in first time VTE patients who later develop a secondary event indicates that df may identify those at risk of recurrence. |
published_date |
2015-02-01T08:03:31Z |
_version_ |
1828998203962294272 |
score |
11.058203 |